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 Pyridazines are heterocyclic compounds with an N-N bond in their ring structure. 
Heterocyclic aromatic compounds are of great interest as a result of their novel properties 
and commercial applications. Our current research is focused on the potential role of 
pyridazines in next generation electronic devices that utilize organics as the 
semiconducting material. The synthesis of 5, 6-fused ring pyridazines beginning from 
fulvenes (Scheme 1) is described herein. These fused heterocycles will serve as synthetic 
models and building blocks for potential organic or organometallic conducting polymers. 
 Our goal was to modify the route of Snyder et al. previously reported for the 
direct synthesis of pyridazine 2.  This required improved synthesis of fulvene 1 and 
higher yields of 5.  Additionally, a thorough analysis of the x-ray data was obtained to 
better understand the 3D aspects of this compound (pyridazine 2).This route was quite 
general and features an efficient and convenient synthesis. 
  Single crystal X-ray analysis confirms the molecular structure of pyridazine 2. 
Full synthesis and characterization of newly formed pyridazine 2 and Fulvene 1 are 
reported. 
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I.  INTRODUCTION 
Pyridazine Background 
  Pyridazines and their derivatives, although known for a century, received 
tremendous attention with the recent discovery of medicinally useful compounds. 
Pyridazines are heteroaromatic, 6-membered organic compounds that are structurally 
important in several biologically active substances with a broad range of biological and 
pharmaceutical activities.  The pyridazine ring system is a 1, 2- diazine or o- diaza 
benzene.  It is a planar molecule for having a maximum of two kekule structures (Figure 
1) possible.1 Historically, pyridazines were first named by Knorr2, while Fischer3 
prepared the first substituted compounds but Tauber4 was the first to synthesize the 
unsubstituted pyridazine (Figure 1).  At room temperature, it is a colorless liquid with 
pyridine(Figure 2)  like odor, owing to its imine functional groups, and has a relatively 
high boiling point (208 0C) and  low melting point (-8 0C).  
The pyridazine molecule is a π-deficient heteroaromatic compound similar to pyridine.  
Due to the presence of the π-deficient nitrogen aromatic heterocycles these compounds 
are more easily soluble in water when compared to other hydrocarbons. The basic 
aromatic ring system of pyridazine contains two adjacent nitrogen atoms (Figure 1). 
These nitrogen atoms offer unique chemistry for this compound.  The presence of 
multiple nitrogen atoms in these compounds allows them to interact with suitable 
substrates with acidic functional groups to generate supramolecular complexes.5 
additionally; pyridazines are effective water oxidation catalysts with high efficiency 
turnover numbers up to 700.6 
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Figure 1: Kekule structure for pyridazine. 
 
 
 
 
                                                                                             
 
Figure 2: Structure for pyridine  
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Pyridazine Uses 
 Most of the biologically active compounds like Minaprine (Figure 3), Gabazine 
(Figure 4), and Hydralazine (Figure 5) have pyridazine as a recurring structural 
component.  Pyridazines have no household use but are mostly found in research and 
industry as a building block for most of the complex organic compounds.7 Pyridazines 
are also useful intermediates in the synthesis of various other heterocycles and in physical 
organic chemistry.  3,6-Di(pyridin-2-yl)pyridazines (DPPs) are well-known ligands for 
the self-assembly of [2 × 2] grid like metal complexes with copper (I) and silver (I) ions, 
which show unique properties.8  The functionalized pyridazines are also versatile 
building blocks in natural-product syntheses.  
There are a myriad of uses for pyridazines elsewhere.  Pyridazines are also known 
to exhibit versatile biological activities such as antibacterial, antibiotic, anti-depressant, 
anti-diabetic, anti-hypertensive, analgesic, anti-tumor, antiviral, nephrotropic, anti-
inflammatory, anti-viral, anti-cancer, anti-aggregative, anti-epileptic.9  These compounds 
are also used in treating sleep disorders including insomnia and for inducing sedation-
hypnosis, anesthesia, sleep and muscle relaxation. The pyridazine structure is also found 
within a number of herbicides such as Credazine (Figure 6), Pyridafol (Figure 7) and 
Pyridate (Figure 8).10 
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    Figure 3: Structure of the psychotropic drug 1-Minaprine. 
 
 
    
       
 
          Figure 4: Structure of the psychotropic drug 2-gabazine (R=OMe, R1 = H, X = B 
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    Figure 5: Structure of the psychotropic drug 3-Hydralazine 
                                 
                                   
 
              Figure 6: Structure of an Herbicide –Credazine 
 
                                      
                                           
              Figure 7: Structure of an Herbicide-Pridafol 
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Figure 8: Structure of an Herbicide-Pyridate 
 
 
                                                     
 
 
                                              
 
 
 
 
                          Figure 9: Structure of an Herbicide-PyrroloPyridazine 
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Additionally, pyridazines are also known for their work as efficient electron 
acceptors in conjugated systems, and as ligands in the synthesis of several novel 
coordination complexes.  Above all, substituted pyridazine-based compounds are 
extensively investigated with regard to their versatile applications.  These substituted 
compounds are used as stearl-CoA desaturase inhibition, and against cyclooxygenase 
enzyme, acetylcholine esterase, aldose reductase as inhibitors.11 
  Pyridazines interfere in various regulation processes of the enzymes and 
find wide applications in drug design.  Analogously, agricultural science takes advantage 
of their high biological activity, and pyridazines whose substitution patterns have been 
modified promote powerful fungicide properties. Among substituted pyridazines the 3-
aminopyridazine unit has been proven to be interesting from pharmacological point of 
view.  For example, Minaprine is a psychotropic drug, which is presently used as an 
antidepressant.  Several derivatives of 3-amino pyridazines also act as selective GABA-A 
receptor antagonists.12  
 Pyridazines are also identified as PIM kinase inhibitors, responsible for invitro 
Anti leukemic activity. These compounds also have a rapid systemic effect on the plants 
and are active at very low concentrations. Some of the pyridazine derivatives have their 
chemical structures related to phytohormones and some plant growth regulators.  In 
addition, similar chemical structures occur in living cells that are involved in various 
biochemical reaction pathways.  Some newly synthesized pyridazine derivatives were 
also used in many research fields due to their structure, stability and reactivity and their 
tendency to form stable compounds with useful biological properties.13 
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Pyridazines can also be used as novel therapeutic agents to target Alzheimer’s 
disease and other neurodegenerative diseases like Parkinson.  Recent studies indicate 
pyridazine derivatives can be used in the treatment of dermatosis, prostate cancer, and dry 
eye disorders.  Moreover, pyridazines are pharmaceutically acceptable acid-addition salts 
that are used as an active component in cardiotonic compositions to increase cardiac 
contractility.14 
Furthermore, simple pyridazines show high halogen-free flame retardant capacity. 
These compounds have also been used as ligands in co-ordination chemistry unlike the 
N-atom donor ligands; pyridazines are not well studied from a crystal engineering 
perspective because of which these compounds are scarcely been explored for crystal 
design.  Pyridazines have also been incorporated into iptycene frameworks, compounds 
researched for conjugated polymer sensors, high mechanical performance polymers, gas 
absorption/storage, and host-guest chemistry and in liquid crystals.15 
Interestingly, Boger and coworkers reported pyrrole synthesis when treating 
pyridazines to a solution of activated zinc in acetic acid (Figure 9).  This has vast 
importance and novelty in the field of semiconducting polypyrroles.  Moreover, 
pyridazines serves as synthetic models and building blocks for organic and 
organometallic polymers which are suitable for a variety of real world applications such 
as Organic Light Emitting Diodes (OLEDs) and Organic Photovoltaic Cell (OPVs). 
Pyrrolopyridazine (Figure 10), which is a derivative of pyridazine, have fluorescent 
properties and are used in sensors, lasers, and also in vulcanization of rubber.  These 
derivatives are also used in treatment of variety of disorders such as hypersecretion of 
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CRF, and also show anti proliferative, anxioltic activity. In addition these compounds are 
also used in treatment of glaucoma.16 
 
 
 
 
                    
 
                    
 
 
 
                Figure 10:  Boger and coworkers convert pyridazines to pyrroles. 
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Pyridazines also has the properties of conducting electricity. These compounds 
possess properties such as good resistivity at room temperature, low density and can be 
stretchable to form thin films.  Additionally, these conductive polymers can be 
incorporated into nanoparticles.  Hence, this compound has been extensively used by the 
electronic industries as packing and insulating materials.  This class of compounds was 
found to have either zero band gap or very small band gap.17 
Molecular electronic materials also possess several advantages over inorganic 
semiconductor materials including lower cost of production, higher processibility and 
ability to function on flexible substrates. Polypyridazine (Figure 11C) and their organic 
derivatives have been well researched; polyfuran (Figure 11D) chemistry has been largely 
unexplored. Unlike thiophenes, pyrroles, and pyridazines, furans can be derived directly 
and catalytically from biomass.  Some of these processes are intentional, while others are 
seen as unwanted by-products or major components in waste streams in the Biorefinery 
sector. For example, the acid-catalyzed depolymerization and dehydration of cellulose 
from agricultural or forest activities produces furfural (Figure 11E). This industrial 
process is responsible for a yearly worldwide output of ~ 300,000 tons. Furfural is also 
utilized for conversion to furfuryl alcohol (Figure 11F), which is a precursor to different 
types of resins and carbonaceous materials.18 
Fused-ring heterocycles like cyclopenta[c]thiophenes (Figure 11G) offer a unique 
opportunity for conducting polymers or they can be incorporated into metal η5-
cyclopenta[c]thienyl complexes for catalysis and materials chemistry. Several alkyl and 
aryl 1, 3-disubstituted cyclopenta[c]theinyl complexes (Figure 11H) have been recorded 
in the literature.  Methyl, thienyl and substituted thienyl, and phenyl 1-3-disubstituted 
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metal η5-cyclopenta[c]thienyl complexes have been synthesized in high yields.  In 
addition, an analogous 5, 6-fused ring pyridazine complex has been reported in RuCp* 
systems.19 
However, to date, there are no reports of tricarbonyl metal cyclopenta[c]pyridazyl 
complexes (Figure 11I) and none that incorporate furyl substituents. We envision 
manganese and rhenium 1, 4-difurylcyclopenta[c]pyridazyl complexes (Figure 11J) 
having a large potential for utilization in electronic materials (e.g., Solar cells) using the 
reported alkyl and aryl thiophene and pyridazine chemistry as a synthetic guide.  In 
addition, those materials that incorporate furan derivatives will have the added benefit of 
incorporating renewable feedstocks into the electronic framework.20 
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        Figure 11: Structures of some heterocyclic compounds A-J 
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Our recent efforts have been focused on the synthesis of a variety of 5,6-fused 
ring pyridazines (Figure 12). These, fused-ring pyridazines are synthesized beginning 
from fulvenes (Scheme 1).  These fused heterocycles will serve as synthetic models and 
building blocks for potential organic or organometallic conducting polymers.21 
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    Figure 12: Structure of a 5, 6-fused ring pyridazine. 
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II. EXPERIMENTAL 
All reactions were carried out using standard Schlenk techniques under a nitrogen 
atmosphere unless otherwise noted. NMR solvents CDCl3 and DMSO-d6 (Aldrich) were 
used without further purification. nBuLi, dicyclopentadiene, methanol, hydrazine 
hydrate, and 2-furoyl chloride (Aldrich) were used without further purification.  Fulvene 
C5H3 (COC4H3O)(COHC4H3O) (1) was prepared according to the literature methods.
21
  
Ethyl ether was dried over sodium benzophenone ketyl. 
1H and 13C NMR spectra were recorded on a JEOL-500 MHz NMR spectrometer 
at ca. 22 oC and were referenced to residual solvent peaks.  All13C NMR spectra were 
listed as decoupled.  Infrared spectra were recorded on Spectrum One FT-IR 
Spectrometer. Electron ionization (EI) mass spectra were recorded at 70 eV on a Varian 
Saturn GC/MS. Melting points were taken on a standard Mel-Temp apparatus.  X-ray 
diffraction data were collected at 90 K on a Nonius KappaCCD diffractometer at the 
University of Kentucky X-ray Crystallographic Laboratories.  Elemental analysis was 
performed at Western Kentucky University’s Advanced Materials Institute. 
 
Synthesis of 1, 2-C5H3 (COC4H3O) (COHC4H3O) (1)  
Freshly cracked cyclopentadiene (3.14 mL, 2.51 g, and 38.1 mmol) was added 
dropwise to a cooled solution (0 oC) of n-butyllithium (16.2 mL of 2.50 M, 23.4 g, 40.5 
mmol) in ethyl ether (120 mL). A white precipitate of cyclopentadienyllithium was 
formed immediately. The suspension was stirred for 10 minutes and 2-furoyl chloride 
(2.48 mL, 3.29 g, and 25.2 mmol) was added dropwise. A bright orange color formed 
immediately. The solution was stirred for 45 minutes at room temperature. The reaction 
mixture was hydrolyzed with dilute (3%) acetic acid (100 mL). The organic layer was 
separated, and the aqueous layer was extracted twice more with ethyl ether (2 x 10 mL). 
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The combined ethyl ether extracts were dried (MgSO4) and removed under reduced 
pressure to leave red oil. The oil was eluted through a silica plug (50:50 dichloromethane: 
hexane) to give an orange solution. The organic solution was removed under reduced 
pressure to leave an orange semi-solid. The solid was triturated with hexane (2 x 10 mL) 
to leave a bright orange solid (337 mg, 1.33 mmol, 10.5%).  Mp: 109–110 oC.  1H NMR 
(500 MHz, CDCl3 ppm): δ 6.07 (t, 1H, 3J = 4 Hz, CHCHCH), 6.62 (dd, 1H,3JAB = 3.5 
Hz, 3JAC = 1.7 Hz CHCHCHO), 7.40 (d, 1H, 3JBC = 3.5 Hz, CHCHCHO), 7.72 (d, 1H, 
3JAB= 1.7 Hz, CHCHCHO), 8.15 (d, 1H, 3J = 4 Hz, CHCHCH).  13C NMR (125 MHz, 
CDCl3, ppm): δ 83.8 (CHCCO), 112.5 (CHCHCH), 119.8 (CHCHCH), 123.5 (CCO), 
124.1, 139.3, 146.9 (Fr), 152.0 (OCCO), 169.3 (CO).  IR (KBr, cm-1):  1530, 1565 
(COC4H3O), 3076, 3115, 3134, 3143 (C–H).  MS: m/z 254 (M+), 186 (M+ – C4H3O), 
119 (M+ – 2C4H3O).  Anal. Calcd. For C15H10O2: C, 70.86; H, 3.96.  Found:  C, 67.56; 
H, 3.56. 
 
Synthesis of 1, 2-C5H3 (CC6H4OCH3NH) (CC6H4OCH3N) (2) 
1, 2-C5H3 (COC6H4OCH3) (COHC6H4OCH3) (1g, 383 mg, 1.15 mmol) was 
dissolved in 50 mL of methanol in a 200 mL round-bottom flask. An excess of hydrazine 
hydrate (1.00 mL, 1.03 g, 20.6 mmol) was added to the solution. The solution was stirred 
24 hours.  To the reaction, water (20 mL) was added and an orange precipitate formed 
immediately. The aqueous suspension was washed with ethyl ether (3 x 10 mL) and the 
organic layers were collected, dried (MgSO4), and filtered. The volatiles were removed 
in vacuo and the crude product was triturated with cold hexane to give 1, 2-
C5H3(CC6H4OCH3NH)(CC6H4OCH3N) (2, 262 mg, 0.793 mmol, 69.2%) as a yellow 
solid.  Mp:  180-184 oC.  1H NMR (500 MHz, CDCl3, ppm): δ 3.90 (s, 3H, CH3), 6.96 
(d, 1H, 3J = 8.6 Hz, OCHCH), 7.07 (d, 1H, 3J = 3.4 Hz, CHCHCH), 7.54 (t, 1H, 3J = 3.4 
Hz, CHCHCH), 7.85 (d, 1H, 3J = 8.6 Hz, OCCHCH), 12.1 (br s, 1H, NH).  13C NMR 
(125 MHz, CDCl3, ppm): δ 55.4 (OCH3), 108.8 (CHCHCH), 114.3 (CHCHCH), 120.2 
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(CCN), 130.0, 131.9 (Ph) 161.0 (CHCHCN).  IR (KBr, cm-1):  1573 (CN), 2934, 2963 
(CH3), 3057 (N-H). MS: m/z 298 (M+ – HOCH3), 239 (M+ – C6H4OCH3). Anal. 
Calcd. For C21H18N2O2: C, 76.34; H, 5.49.  Found: C, 74.32; H, 6.30. 
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III. RESULTS AND DISCUSSIONS 
Impetus of Research Project 
 
Pyridazine 2 was already obtained indirectly through the attempted 
recrystallization of pyridazine complexes (scheme 3) 4A–B.  The ligand was apparently 
too labile to remain fused to the transition metal center (Mn and Re).  As a result 
pyridazine 5 was obtained by ligand loss.  Our goal was to modify the route Snyder et al. 
previously reported for the direct synthesis of pyridazine 2.  This required improved 
synthesis of fulvene 1 and higher yields of 5.  Additionally, a thorough analysis of the x-
ray data was obtained to better understand the 3D aspects of this compound (pyridazine 
2). 
 
Synthesis of 1, 2-C5H3 (COC4H3O) (COHC4H3O) (1) 
Fulvene (1) was synthesized by initial addition of freshly cracked cyclopentadiene 
in a dropwise manner to a cooled solution of n-butyllithium in ethyl ether, which resulted 
in a white precipitate of cyclopentadienyllithium (Scheme 1). Then the suspension was 
stirred followed by a dropwise addition of 2-furoyl chloride that quickly results in a 
bright orange color. The bright orange color solution was then stirred at room 
temperature. After the solution was hydrolyzed with dilute acetic acid the reaction 
underwent an organic extraction.   The red oil was eluted through a silica plug using the 
solvent to give an orange solution.  The organic solution was removed under reduced 
pressure to leave an orange semi-solid.   The semi-solid was found to be impure and as a 
result the crude fulvene had to be eluted through a silica plug for a second time.  This 
time we collected only the yellow band.  After reducing the organic in vacuo, a bright 
orange powder was obtained after purification with yields approximately of 48%.  Our 
modification to the purification step improved yields from 10% to 48%!  Fulvene 1 
required no further purification and gave excellent characterization data.  
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Scheme 1.  Reported synthesis of fulvenes 1a–h.  Fulvene 1e is listed as fulvene 1 in this 
thesis. 
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Spectroscopy of 1, 2-C5H3 (COC4H3O) (COHC4H3O) (1) 
 
As reported by Snyder and colleagues, fulvene 1 shows a doublet (8.15 ppm, 
CHCHCH) and triplet (6.07 ppm, CHCHCH) in its 1H NMR spectrum owing to the 
cyclopentadienide (Cp) ring structure.  Both signals were coupled at strength of 4 Hz, 
typical of Cp ring coupling constants.  Its 13C NMR showed the C=O carbon at 169.3 
ppm as expected for carbonyl carbon atoms.  All other relevant furoyl rings carbons were 
observed in the aromatic section of the spectrum.  Cp ring carbons were also observed at 
112.5 (CHCHCH) and 119.8 (CHCHCH), which is expected for Cp carbons.  IR showed 
the typical carbonyl stretches at 1530 and 1565 cm-1.  These numbers are low for the 
typical carbonyl stretch but not unexpected.  This system is a delocalized 1,4-diketone 
which inherently lowers the wavenumbers for C=O stretching.  EI-MS confirmed its 
molecular weight having an M+ = 254 m/z.  The mass spectrum also showed evidence of 
furoyl loss 186 (M+ – C4H3O) followed by a second loss (M+ – 2C4H3O).  Unfortunately 
elemental analysis was not as close as we would have liked but we have been working to 
improve those results.  Fulvene 1 (Figure 13) was also characterized by X-ray 
crystallography by other members of the Snyder Research group. 
 
Synthesis of 1, 2-C5H3 (CC6H4OCH3NH) (CC6H4OCH3N) (2) 
 
Pyridazine (2) was synthesized by addition of excess hydrazine hydrate in 
methanol to a solution of 1,2-C5H3(COC6H4OCH3)(COHC6H4OCH3) in methanol and 
were allowed to stir for 24 hours at room temperature (Scheme 2).  Water was added to 
the reaction mixture to precipitate the product so it could be then be extracted with 
diethyl ether.  After the volatiles were removed an orange precipitate formed and was 
triturated with cold hexane. A yellow powder was obtained after purification with at a 
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69% yield. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 2.  Reported synthesis of pyridazines 2a–h.  Fulvene 1e is listed as pyridazine 2 
in this thesis. 
 
 
22 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 13:  Molecular structure of fulvene 1. 
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Spectroscopy of 1,2-C5H3(CC6H4OCH3NH)(CC6H4OCH3N) (2) 
 
The most noticeable difference between fulvene 1 and pyridazine 2 is loss of the 
carbonyl carbon in the 13C NMR spectra, the broad singlet at d12.1 owing to the amine 
proton (Figure x), loss of C=O stretch in the IR spectrum and simultaneous gain of the 
C=N stretch (1573 cm-1).   EI-MS showed loss of methanol but failed to show a true 
molecular ion signal.  Attempts to improve the faulty EA have been undertaken.  
However, the molecular structure for pyridazine 2 was obtained by x-ray crystallography 
(Figure 14). 
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Scheme 3: Indirect synthesis of pyridazine 5 that led to its crystal structure 
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Figure 14: 1H NMR spectra for pyridazine 2. 
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Figure 15:  1H NMR spectra for pyridazine 2 showing coupling. 
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X-Ray Analysis of 1, 2-C5H3 (CC6H4OCH3NH) (CC6H4OCH3N) 
 
Compound 2 crystallizes in the monoclinic space group, P 21 with two molecules 
in the asymmetric unit (Distinguished as “A” and “B”).  The furyl rings for molecule A 
are anti-periplanar with respect to each other and nearly coplanar to the central pyridazine 
ring, with the dihedral angles for [C3A–C4A–C5A–N1A] and [N2A–C11A–C12A–O2A] 
being 4.6(5)o and 9.7(4)o, respectively. In contrast, the furyl rings for molecule B are syn-
periplanar with respect to each other and nearly coplanar to the central pyridazine ring, 
with the dihedral angles for [N2B–C11B–C12B–O2B] and [O1B–C4B–C5B–N1B] at -
8.3(4)o and 13.2(4)o, respectively.  The central pyridazyl Cp ring is highly planar, with the 
root-mean-square deviation from the planes created by N1, N2, C5–C12 in molecules A 
and B at 0.006(2) Å and 0.014(2) Å, respectively.  The imine carbon bond lengths, N1A–
C5A and N1B–C5B, are relatively equidistant at 1.340(4) and 1.329(4) Å, respectively.  
The Cp ring average bond length (C6A–C7A; C7A–C8A; C8A–C9A; C9A–C10A) is 
1.402(9) Å, with the C6A–C10A bond length significantly longer (1.465(4) Å) compared 
to the other four Cp bonds. The C=C bonds within the furan portion of 5 are significantly 
shorter than those in the pyridazine ring.  For example, the bond lengths for C1A–C2A 
and C3A-C4A are 1.347(4) and 1.359(4) Å, respectively, compared to those of C6-C7A 
(1.400(4) Å) and C9-C10A (1.410(4) Å).  This observation most likely reflects the furan 
delocalized π system versus the non-aromatic Cp ring.  A pair of hydrogen bonds link the 
amine groups of each unique molecule (N2A–H2NA and N2B–H2NB) and the imine 
nitrogen on the adjacent molecule (N1A and N1B), with hydrogen bond distances 
(N1….H2N) at 2.886(3) and 2.961(3) Å, respectively.  This causes an inverted 
 
 
28 
arrangement for each unique molecule with respect to the other, with the furyl ring that 
contains O1A in molecule A; adjacent to the furyl ring that contains O2B in molecule B. 
Analysis of compound 5 does show some π-stacking in the solid state.  For 
molecule A, the adjacent stacked molecule, generated by the (x,y,z) to (x, y-1, z) 
transformation, is arranged “face-to-face” and slightly offset.  This planar arrangement 
can be best observed along the crystallographic b axis (Figure 16).  The pyridazyl portion 
within one layer is aligned with the furyl ring of the adjacent layer (Figure 16, top).  A 
short contact (a distance less than the sum of the Vander Waals radii) is observed between 
C15A and N1A (3.245 Å).  Furthermore, other analogous distances between the stacked 
layers are well within the commonly accepted values (3.4 to 3.6 Å) for evidence of π-
stacking (e.g., C3A to N2A is 3.381 Å).  Planes created by adjacent layers of molecule A 
also indicate a high degree of π-stacking, with an inter-planar distance of 3.355 Å.  By 
contrast, while molecule B does display a coplanar stacking arrangement between layers, 
the relative molecule placement is very different (Figure 16, bottom). There is far less 
evidence of π-orbital overlap as compared to the arrangement for molecule A, and no 
short contacts are observed between adjacent layers of molecule B.  While there does 
appear to be some evidence of π-π interaction (e.g., with the distance between C8B and 
O2B is 3.3376 Å) the interlayer distances between most atoms are too far for orbital 
overlap to occur.  This is not due to the actual distance between the stacked layers of 
molecule B (the distance calculated between those two planes created by B is 3.273 Å). 
Instead, it is a greater displacement between these stacked molecules in molecule B that 
makes the actual amount of π-π interaction weak.  Only the Cp portion of one layer and 
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the furyl ring containing O2B of the adjacent layer have any significant overlap for 
molecule B. 
Tables of crystallographic details, atomic coordinates and displacement 
parameters, bond distances and angles, intermolecular contact distances, structure factors 
and a crystallographic information file (CIF) for the structure of 2 have been deposited 
with the Cambridge Crystallographic Data Centre. 
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Figure 16: Molecular structure of 1, 2-C5H3 (CC6H4OCH3NH) (CC6H4OCH3N) (2). 
 
 
31 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
      Figure 17:  3D view for π-stacking potential in the solid state. 
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Table 1: Crystal data and structure refinement for pyridazine 2 
 
 
Identification code k10178 
Empirical formula C15 H10 N2 O2 
Formula weight 250.25 
Temperature 90.0(2) K 
Wavelength 0.71073 A 
Crystal system, space group Monoclinic,  P 21 
Unit cell dimensions a = 12.8754(2) A   alpha = 90 deg. 
 b = 5.90380(10) A    beta = 
105.0649(6) deg. 
 c = 15.5817(2) A   gamma = 90 deg. 
Volume 1143.72(3) A^3 
Z, Calculated density 4,  1.453 Mg/m^3 
Absorption coefficient 0.099 mm^-1 
F(000) 520 
Crystal size 0.20 x 0.18 x 0.06 mm 
Theta range for data collection 1.35 to 27.47 deg. 
Limiting indices -16<=h<=16, -7<=k<=7, -
20<=l<=20 
Reflections collected / unique 26530 / 2887 [R(int) = 0.0630] 
Completeness to theta = 27.47 100.00% 
Absorption correction Semi-empirical from equivalents 
Max. and min. transmission 0.994 and 0.981 
Refinement method Full-matrix least-squares on F^2 
Data / restraints / parameters 2887 / 1 / 343 
Goodness-of-fit on F^2 1.05 
Final R indices [I>2sigma(I) R1 = 0.0472, wR2 = 0.1135 
R indices (all data) R1 = 0.0747, wR2 = 0.1267 
Largest diff. peak and hole 0.300 and -0.259 e.A^-3 
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Table 2:  Atomic coordinates (x 10^4) and equivalent isotropic displacement parameters 
(A^2 x 10^3) for k10178.  U (eq) is defined as one third of the trace of the 
orthogonalized Uij tensor. 
 
x y z U(eq)  
O(1A) 5539(2) -1490(4) 4068(1) 28(1) 
N(1A) 4129(2) 2627(5) 2504(1) 23(1) 
C(1A) 5091(3) -3279(6) 4398(2) 29(1) 
O(2A) 4280(2) 8346(4) 1191(1) 32(1) 
N(2A) 4328(2) 4473(5) 2061(2) 23(1) 
C(2A) 4022(3) -3352(6) 4031(2) 29(1) 
C(3A) 3774(2) -1511(6) 3424(2) 26(1) 
C(4A) 4715(2) -411(6) 3471(2) 22(1) 
C(5A) 4986(2) 1579(5) 3028(2) 22(1) 
C(6A) 6048(2) 2374(6) 3133(2) 21(1) 
C(7A) 7065(2) 1662(6) 3627(2) 29(1) 
C(8A) 7819(2) 3196(7) 3450(2) 30(1) 
C(9A) 7315(2) 4882(6) 2862(2) 28(1) 
C(10A) 6203(2) 4416(6) 2646(2) 22(1) 
C(11A) 5294(2) 5434(5) 2103(2) 22(1) 
C(12A) 5275(2) 7439(6) 1570(2) 25(1) 
C(13A) 6035(3) 8696(7) 1328(2) 37(1) 
C(14A) 5451(3) 10493(7) 773(2) 38(1) 
C(15A) 4428(3) 10196(7) 715(2) 36(1) 
N(1B) 2072(2) 5618(5) 1535(2) 24(1) 
O(1B) 2097(2) 7270(4) -78(1) 34(1) 
C(1B) 2077(2) 8622(7) -800(2) 34(1) 
N(2B) 1962(2) 4594(5) 2290(2) 25(1) 
O(2B) 1960(2) 1934(4) 3675(1) 31(1) 
C(2B) 1593(3) 10563(8) -744(2) 41(1) 
C(3B) 1291(3) 10513(7) 78(2) 36(1) 
C(4B) 1602(2) 8477(6) 456(2) 26(1) 
C(5B) 1487(2) 7470(6) 1279(2) 23(1) 
C(6B) 793(2) 8364(6) 1763(2) 25(1) 
C(7B) 98(2) 10243(6) 1647(2) 28(1) 
C(8B) -414(3) 10174(7) 2351(2) 32(1) 
C(9B) -68(2) 8332(6) 2892(2) 28(1) 
C(10B) 693(2) 7165(6) 2553(2) 24(1) 
C(11B) 1328(2) 5255(6) 2808(2) 23(1) 
C(12B) 1380(2) 3915(6) 3594(2) 26(1) 
C(13B) 1028(3) 4249(7) 4339(2) 32(1) 
C(14B) 1397(3) 2336(7) 4897(2) 33(1) 
C(15B) 1951(3) 1002(6) 4471(2) 32(1) 
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          Table 3: Bond lengths [A] and angles [deg] for pyridazine 2 
 
  
O(1A)-C(1A) 1.366(4) 
O(1A)-C(4A) 1.373(3) 
N(1A)-C(5A) 1.340(4) 
N(1A)-N(2A) 1.350(4) 
C(1A)-C(2A) 1.347(4) 
C(1A)-H(1A) 0.95 
O(2A)-C(15A) 1.361(4) 
O(2A)-C(12A) 1.372(4) 
N(2A)-C(11A) 1.352(4) 
N(2A)-H(2NA) 0.88 
C(2A)-C(3A) 1.421(5) 
C(2A)-H(2A) 0.95 
C(3A)-C(4A) 1.359(4) 
C(3A)-H(3A) 0.95 
C(4A)-C(5A) 1.451(4) 
C(5A)-C(6A) 1.414(4) 
C(6A)-C(7A) 1.400(4) 
C(6A)-C(10A) 1.465(4) 
C(7A)-C(8A) 1.407(5) 
C(7A)-H(7A) 0.95 
C(8A)-C(9A) 1.393(5) 
C(8A)-H(8A) 0.95 
C(9A)-C(10A) 1.410(4) 
C(9A)-H(9A) 0.95 
C(10A)-C(11A) 1.390(4) 
C(11A)-C(12A) 1.443(4) 
C(12A)-C(13A) 1.357(5) 
C(13A)-C(14A) 1.450(5) 
C(13A)-H(13A) 0.95 
C(14A)-C(15A) 1.309(5) 
C(14A)-H(14A) 0.95 
C(15A)-H(15A) 0.95 
N(1B)-C(5B) 1.329(4) 
N(1B)-N(2B) 1.363(3) 
O(1B)-C(4B) 1.371(4) 
O(1B)-C(1B) 1.375(4) 
C(1B)-C(2B) 1.318(6) 
C(1B)-H(1B) 0.95 
N(2B)-C(11B) 1.345(4) 
N(2B)-H(2NB) 0.88 
O(2B)-C(15B) 1.360(4) 
O(2B)-C(12B) 1.376(4) 
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C(2B)-C(3B) 1.432(5) 
C(2B)-H(2B) 0.95 
C(3B)-C(4B) 1.353(5) 
C(3B)-H(3B) 0.95 
C(4B)-C(5B) 1.455(4) 
C(5B)-C(6B) 1.413(4) 
C(6B)-C(7B) 1.408(5) 
C(6B)-C(10B) 1.454(4) 
C(7B)-C(8B) 1.420(4) 
C(7B)-H(7B) 0.95 
C(8B)-C(9B) 1.377(5) 
C(8B)-H(8B) 0.95 
C(9B)-C(10B) 1.408(4) 
C(9B)-H(9B) 0.95 
C(10B)-C(11B) 1.389(5) 
C(11B)-C(12B) 1.446(4) 
C(12B)-C(13B) 1.365(4) 
C(13B)-C(14B) 1.429(5) 
C(13B)-H(13B) 0.95 
C(14B)-C(15B) 1.348(5) 
C(14B)-H(14B) 0.95 
C(15B)-H(15B) 0.95 
C(1A)-O(1A)-C(4A) 106.6(2) 
C(5A)-N(1A)-N(2A) 116.6(2) 
C(2A)-C(1A)-O(1A) 110.5(3) 
C(2A)-C(1A)-H(1A) 124.8 
O(1A)-C(1A)-H(1A) 124.8 
C(15A)-O(2A)-C(12A) 107.5(3) 
N(1A)-N(2A)-C(11A) 127.4(3) 
N(1A)-N(2A)-H(2NA) 116.3 
C(11A)-N(2A)-H(2NA) 116.3 
C(1A)-C(2A)-C(3A) 106.6(3) 
C(1A)-C(2A)-H(2A) 126.7 
C(3A)-C(2A)-H(2A) 126.7 
C(4A)-C(3A)-C(2A) 106.7(3) 
C(4A)-C(3A)-H(3A) 126.6 
C(2A)-C(3A)-H(3A) 126.6 
C(3A)-C(4A)-O(1A) 109.6(3) 
C(3A)-C(4A)-C(5A) 133.1(3) 
O(1A)-C(4A)-C(5A) 117.4(3) 
N(1A)-C(5A)-C(6A) 122.4(3) 
N(1A)-C(5A)-C(4A) 113.7(3) 
C(6A)-C(5A)-C(4A) 124.0(3) 
C(7A)-C(6A)-C(5A) 134.6(3) 
C(7A)-C(6A)-C(10A) 107.3(3) 
C(5A)-C(6A)-C(10A) 118.1(3) 
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C(6A)-C(7A)-C(8A) 107.1(3) 
C(6A)-C(7A)-H(7A) 126.5 
C(8A)-C(7A)-H(7A) 126.5 
C(9A)-C(8A)-C(7A) 111.2(3) 
C(9A)-C(8A)-H(8A) 124.4 
C(7A)-C(8A)-H(8A) 124.4 
C(8A)-C(9A)-C(10A) 106.7(3) 
C(8A)-C(9A)-H(9A) 126.6 
C(10A)-C(9A)-H(9A) 126.6 
C(11A)-C(10A)-C(9A) 134.7(3) 
C(11A)-C(10A)-C(6A) 117.7(3) 
C(9A)-C(10A)-C(6A) 107.7(3) 
N(2A)-C(11A)-C(10A) 117.8(3) 
N(2A)-C(11A)-C(12A) 116.0(3) 
C(10A)-C(11A)-C(12A) 126.2(3) 
C(13A)-C(12A)-O(2A) 109.1(3) 
C(13A)-C(12A)-C(11A) 134.7(3) 
O(2A)-C(12A)-C(11A) 116.2(3) 
C(12A)-C(13A)-C(14A) 105.4(3) 
C(12A)-C(13A)-H(13A) 127.3 
C(14A)-C(13A)-H(13A) 127.3 
C(15A)-C(14A)-C(13A) 107.4(3) 
C(15A)-C(14A)-H(14A) 126.3 
C(13A)-C(14A)-H(14A) 126.3 
C(14A)-C(15A)-O(2A) 110.6(3) 
C(14A)-C(15A)-H(15A) 124.7 
O(2A)-C(15A)-H(15A) 124.7 
C(5B)-N(1B)-N(2B) 116.5(2) 
C(4B)-O(1B)-C(1B) 106.4(3) 
C(2B)-C(1B)-O(1B) 111.0(3) 
C(2B)-C(1B)-H(1B) 124.5 
O(1B)-C(1B)-H(1B) 124.5 
C(11B)-N(2B)-N(1B) 127.2(3) 
C(11B)-N(2B)-H(2NB) 116.4 
N(1B)-N(2B)-H(2NB) 116.4 
C(15B)-O(2B)-C(12B) 107.1(2) 
C(1B)-C(2B)-C(3B) 106.5(3) 
C(1B)-C(2B)-H(2B) 126.7 
C(3B)-C(2B)-H(2B) 126.7 
C(4B)-C(3B)-C(2B) 106.8(3) 
C(4B)-C(3B)-H(3B) 126.6 
C(2B)-C(3B)-H(3B) 126.6 
C(3B)-C(4B)-O(1B) 109.2(3) 
C(3B)-C(4B)-C(5B) 131.3(3) 
O(1B)-C(4B)-C(5B) 119.5(3) 
N(1B)-C(5B)-C(6B) 122.3(3) 
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N(1B)-C(5B)-C(4B) 114.9(3) 
C(6B)-C(5B)-C(4B) 122.8(3) 
C(7B)-C(6B)-C(5B) 134.0(3) 
C(7B)-C(6B)-C(10B) 107.4(3) 
C(5B)-C(6B)-C(10B) 118.5(3) 
C(6B)-C(7B)-C(8B) 106.6(3) 
C(6B)-C(7B)-H(7B) 126.7 
C(8B)-C(7B)-H(7B) 126.7 
C(9B)-C(8B)-C(7B) 110.7(3) 
C(9B)-C(8B)-H(8B) 124.6 
C(7B)-C(8B)-H(8B) 124.6 
C(8B)-C(9B)-C(10B) 107.7(3) 
C(8B)-C(9B)-H(9B) 126.2 
C(10B)-C(9B)-H(9B) 126.2 
C(11B)-C(10B)-C(9B) 134.9(3) 
C(11B)-C(10B)-C(6B) 117.5(3) 
C(9B)-C(10B)-C(6B) 107.6(3) 
N(2B)-C(11B)-C(10B) 117.9(3) 
N(2B)-C(11B)-C(12B) 116.6(3) 
C(10B)-C(11B)-C(12B) 125.5(3) 
C(13B)-C(12B)-O(2B) 109.7(3) 
C(13B)-C(12B)-C(11B) 133.6(3) 
O(2B)-C(12B)-C(11B) 116.6(3) 
C(12B)-C(13B)-C(14B) 105.8(3) 
C(12B)-C(13B)-H(13B) 127.1 
C(14B)-C(13B)-H(13B) 127.1 
C(15B)-C(14B)-C(13B) 107.3(3) 
C(15B)-C(14B)-H(14B) 126.4 
C(13B)-C(14B)-H(14B) 126.4 
C(14B)-C(15B)-O(2B) 110.1(3) 
C(14B)-C(15B)-H(15B) 124.9 
O(2B)-C(15B)-H(15B) 124.9 
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Table 4: Anisotropic displacement parameters (A^2 x 10^3) for k10178.  The anisotropic 
displacement factor exponent takes the form:  -2 pi^2 [h^2 a*^2 U11 + ... + 2 h k a* b* 
U12] 
  
     
U11 U22 U33 U23 U13 U12       
O(1A) 28(1) 26(1) 27(1) 5(1) 3(1) 2(1) 
N(1A) 25(1) 21(1) 23(1) 1(1) 8(1) 2(1) 
C(1A) 43(2) 20(2) 25(2) 3(1) 11(2) -1(2) 
O(2A) 39(1) 30(1) 28(1) 3(1) 7(1) 2(1) 
N(2A) 23(1) 21(1) 25(1) 2(1) 7(1) 2(1) 
C(2A) 33(2) 26(2) 26(2) 2(2) 4(1) -4(2) 
C(3A) 27(2) 24(2) 25(2) 0(2) 2(1) -2(2) 
C(4A) 28(2) 20(2) 19(1) -2(1) 5(1) 2(2) 
C(5A) 26(2) 19(2) 22(2) -4(1) 10(1) 1(1) 
C(6A) 22(2) 20(2) 23(2) -4(1) 7(1) 1(1) 
C(7A) 31(2) 29(2) 25(2) -5(2) 5(1) 5(2) 
C(8A) 22(2) 40(2) 27(2) -3(2) 6(1) 0(2) 
C(9A) 30(2) 33(2) 24(2) -6(2) 10(1) -4(2) 
C(10A) 24(2) 22(2) 22(2) -5(1) 6(1) -2(1) 
C(11A) 29(2) 17(2) 23(1) -5(1) 12(1) 0(1) 
C(12A) 26(2) 26(2) 25(2) -3(2) 10(1) -2(2) 
C(13A) 30(2) 45(2) 38(2) 4(2) 12(2) -4(2) 
C(14A) 54(2) 32(2) 28(2) 8(2) 14(2) -6(2) 
C(15A) 49(2) 27(2) 29(2) 7(2) 6(2) 3(2) 
N(1B) 24(1) 26(2) 22(1) 2(1) 7(1) -1(1) 
O(1B) 36(1) 38(2) 28(1) 1(1) 10(1) 2(1) 
C(1B) 29(2) 52(2) 21(2) 6(2) 7(1) -7(2) 
N(2B) 27(1) 22(1) 27(1) 3(1) 8(1) 0(1) 
O(2B) 33(1) 32(2) 31(1) 4(1) 13(1) 1(1) 
C(2B) 28(2) 50(3) 44(2) 23(2) 7(2) 2(2) 
C(3B) 31(2) 31(2) 51(2) 2(2) 18(2) 8(2) 
C(4B) 20(1) 32(2) 26(2) -3(2) 8(1) -2(2) 
C(5B) 19(1) 26(2) 24(2) -1(2) 4(1) -5(1) 
C(6B) 21(1) 27(2) 25(2) -1(2) 5(1) -3(2) 
C(7B) 28(2) 28(2) 27(2) 3(2) 6(1) 4(2) 
C(8B) 30(2) 36(2) 31(2) -8(2) 11(1) 4(2) 
C(9B) 27(2) 33(2) 24(2) -1(2) 8(1) -2(2) 
C(10B) 22(2) 25(2) 25(2) -4(1) 5(1) -5(1) 
C(11B) 21(2) 25(2) 23(2) -2(1) 6(1) -6(1) 
C(12B) 18(1) 31(2) 26(2) -4(2) 4(1) -2(1) 
C(13B) 27(2) 38(2) 29(2) -3(2) 6(1) -4(2) 
C(14B) 35(2) 36(2) 27(2) 4(2) 7(1) -6(2) 
C(15B) 36(2) 33(2) 26(2) 7(2) 5(1) -3(2) 
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                  Table 5: Hydrogen coordinates (x 10^4) and isotropic 
                  Displacement parameters (A^2 x 10^3) for pyridazine 2 
  
          
x y z U(eq)  
H(1A) 5479 -4325 4826 35 
H(2NA) 3765 5126 1703 28 
H(2A) 3529 -4425 4153 34 
H(3A) 3085 -1124 3057 32 
H(7A) 7217 385 4010 35 
H(8A) 8574 3096 3698 36 
H(9A) 7655 6109 2648 34 
H(13A) 6790 8450 1489 45 
H(14A) 5755 11670 501 45 
H(15A) 3867 11141 387 43 
H(1B) 2373 8211 -1277 40 
H(2NB) 2347 3365 2458 30 
H(2B) 1470 11761 -1166 49 
H(3B) 940 11684 312 43 
H(7B) -9 11343 1187 34 
H(8B) -925 11252 2438 38 
H(9B) -300 7922 3401 33 
H(13B) 622 5495 4461 38 
H(14B) 1275 2057 5464 39 
H(15B) 2286 -388 4695 39 
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                           Table 6: Torsion angles [deg] for pyridazine 2 
C(4A)-O(1A)-C(1A)-C(2A) -0.1(3) 
C(5A)-N(1A)-N(2A)-C(11A) -2.1(4) 
O(1A)-C(1A)-C(2A)-C(3A) 0.5(4) 
C(1A)-C(2A)-C(3A)-C(4A) -0.8(4) 
C(2A)-C(3A)-C(4A)-O(1A) 0.7(3) 
C(2A)-C(3A)-C(4A)-C(5A) -179.3(3) 
C(1A)-O(1A)-C(4A)-C(3A) -0.4(3) 
C(1A)-O(1A)-C(4A)-C(5A) 179.6(2) 
N(2A)-N(1A)-C(5A)-C(6A) 1.3(4) 
N(2A)-N(1A)-C(5A)-C(4A) -179.0(2) 
C(3A)-C(4A)-C(5A)-N(1A) 4.6(5) 
O(1A)-C(4A)-C(5A)-N(1A) -175.5(2) 
C(3A)-C(4A)-C(5A)-C(6A) -175.7(3) 
O(1A)-C(4A)-C(5A)-C(6A) 4.2(4) 
N(1A)-C(5A)-C(6A)-C(7A) 179.2(3) 
C(4A)-C(5A)-C(6A)-C(7A) -0.4(5) 
N(1A)-C(5A)-C(6A)-C(10A) -0.1(4) 
C(4A)-C(5A)-C(6A)-C(10A) -179.7(2) 
C(5A)-C(6A)-C(7A)-C(8A) -179.6(3) 
C(10A)-C(6A)-C(7A)-C(8A) -0.3(3) 
C(6A)-C(7A)-C(8A)-C(9A) 0.5(4) 
C(7A)-C(8A)-C(9A)-C(10A) 0.5(4) 
C(8A)-C(9A)-C(10A)-C(11A) -179.6(3) 
C(8A)-C(9A)-C(10A)-C(6A) 0.3(3) 
C(7A)-C(6A)-C(10A)-C(11A) 179.9(3) 
C(5A)-C(6A)-C(10A)-C(11A) -0.6(4) 
C(7A)-C(6A)-C(10A)-C(9A) 0.0(3) 
C(5A)-C(6A)-C(10A)-C(9A) 179.4(3) 
N(1A)-N(2A)-C(11A)-C(10A) 1.4(4) 
N(1A)-N(2A)-C(11A)-C(12A) -178.7(2) 
C(9A)-C(10A)-C(11A)-N(2A) 180.0(3) 
C(6A)-C(10A)-C(11A)-N(2A) 0.1(4) 
C(9A)-C(10A)-C(11A)-C(12A) 0.1(5) 
C(6A)-C(10A)-C(11A)-C(12A) -179.8(3) 
C(15A)-O(2A)-C(12A)-C(13A) -0.5(4) 
C(15A)-O(2A)-C(12A)-C(11A) -179.6(2) 
N(2A)-C(11A)-C(12A)-C(13A) -169.1(4) 
C(10A)-C(11A)-C(12A)-C(13A) 10.8(5) 
N(2A)-C(11A)-C(12A)-O(2A) 9.7(4) 
C(10A)-C(11A)-C(12A)-O(2A) -170.4(3) 
O(2A)-C(12A)-C(13A)-C(14A) 0.6(4) 
C(11A)-C(12A)-C(13A)-C(14A) 179.5(3) 
C(12A)-C(13A)-C(14A)-C(15A) -0.5(4) 
C(13A)-C(14A)-C(15A)-O(2A) 0.2(4) 
C(12A)-O(2A)-C(15A)-C(14A) 0.2(4) 
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C(4B)-O(1B)-C(1B)-C(2B) -0.6(4) 
C(5B)-N(1B)-N(2B)-C(11B) -0.2(4) 
O(1B)-C(1B)-C(2B)-C(3B) 1.2(4) 
C(1B)-C(2B)-C(3B)-C(4B) -1.3(4) 
C(2B)-C(3B)-C(4B)-O(1B) 0.9(4) 
C(2B)-C(3B)-C(4B)-C(5B) -178.6(3) 
C(1B)-O(1B)-C(4B)-C(3B) -0.3(4) 
C(1B)-O(1B)-C(4B)-C(5B) 179.4(3) 
N(2B)-N(1B)-C(5B)-C(6B) 0.7(4) 
N(2B)-N(1B)-C(5B)-C(4B) -178.3(3) 
C(3B)-C(4B)-C(5B)-N(1B) -167.3(3) 
O(1B)-C(4B)-C(5B)-N(1B) 13.2(4) 
C(3B)-C(4B)-C(5B)-C(6B) 13.8(6) 
O(1B)-C(4B)-C(5B)-C(6B) -165.7(3) 
N(1B)-C(5B)-C(6B)-C(7B) -179.7(3) 
C(4B)-C(5B)-C(6B)-C(7B) -0.9(6) 
N(1B)-C(5B)-C(6B)-C(10B) -2.0(4) 
C(4B)-C(5B)-C(6B)-C(10B) 176.8(3) 
C(5B)-C(6B)-C(7B)-C(8B) 177.8(3) 
C(10B)-C(6B)-C(7B)-C(8B) -0.1(3) 
C(6B)-C(7B)-C(8B)-C(9B) -0.3(4) 
C(7B)-C(8B)-C(9B)-C(10B) 0.7(4) 
C(8B)-C(9B)-C(10B)-C(11B) 178.5(3) 
C(8B)-C(9B)-C(10B)-C(6B) -0.7(4) 
C(7B)-C(6B)-C(10B)-C(11B) -178.8(3) 
C(5B)-C(6B)-C(10B)-C(11B) 2.9(4) 
C(7B)-C(6B)-C(10B)-C(9B) 0.5(4) 
C(5B)-C(6B)-C(10B)-C(9B) -177.7(3) 
N(1B)-N(2B)-C(11B)-C(10B) 1.2(4) 
N(1B)-N(2B)-C(11B)-C(12B) -178.1(3) 
C(9B)-C(10B)-C(11B)-N(2B) 178.4(3) 
C(6B)-C(10B)-C(11B)-N(2B) -2.5(4) 
C(9B)-C(10B)-C(11B)-C(12B) -2.4(6) 
C(6B)-C(10B)-C(11B)-C(12B) 176.7(3) 
C(15B)-O(2B)-C(12B)-C(13B) 1.2(3) 
C(15B)-O(2B)-C(12B)-C(11B) 177.1(3) 
N(2B)-C(11B)-C(12B)-C(13B) 166.4(3) 
C(10B)-C(11B)-C(12B)-C(13B) -12.9(5) 
N(2B)-C(11B)-C(12B)-O(2B) -8.3(4) 
C(10B)-C(11B)-C(12B)-O(2B) 172.5(3) 
O(2B)-C(12B)-C(13B)-C(14B) -1.2(3) 
C(11B)-C(12B)-C(13B)-C(14B) -176.1(3) 
C(12B)-C(13B)-C(14B)-C(15B) 0.8(4) 
C(13B)-C(14B)-C(15B)-O(2B) -0.1(4) 
C(12B)-O(2B)-C(15B)-C(14B) -0.7(4) 
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                            Table 7: Hydrogen bonds for pyridazine 2 [A and deg.] 
 
  
D-H...A d(D-H) d(H...A) D(D...A) <(DHA) 
 N(2A)-H(2NA)...N(1B) 0.88 2.15 2.886(3) 141.3 
 N(2B)-H(2NB)...N(1A) 0.88 2.32 2.961(3) 129.9 
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                                                              IV. CONCLUSIONS 
  Fulvene 1 and Pyridazine 2 was synthesized with greater purity and in higher 
yields than that what was previously reported by Snyder et al. pyridazyl complexes 1, 2-
C5H3 (COC4H3O) (COHC4H3O) (1) and 2-C5H3 (CC6H4OCH3NH) (CC6H4OCH3N) 
(2) are yellowish orange in color and the synthesis was achieved through  a series of 
organic and organometallic reactions. The percentage yields of the products fulvene 1 and 
pyridazine 2 are found to have good range from 38.0 – 76.0%.  
1H NMR confirmed the presence of cyclopentadienide(Cp) ring structure and 13C 
NMR showed the C=O carbon at 169.3 ppm as expected for carbonyl carbon atoms. IR 
showed the typical carbonyl stretches at 1530 and 1565 cm-1.  EI-MS confirmed its 
molecular weight having an M+ = 254 m/z.  The mass spectrum also showed evidence of 
furoyl loss 186 (M+ – C4H3O) followed by a second loss (M+ – 2C4H3O).Single crystal x-
ray analysis confirmed the molecular structure of pyridazine 2 (Figure 16). Adding to 
their real world capabilities in electronic devices, these compounds display reasonably 
high stability in solution and in air at room temperature. 
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